Concepedia

Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial

Ellen M. Apperloo, José Luis Górriz, María José Soler, Secundino Cigarrán Guldris, Josep M. Cruzado, María Jesús Puchades, Marina López-Martínez, Femke Waanders, Gozewijn D. Laverman, Annemarie van der Aart-van der Beek,

Nature Medicine · 2024 · 97 citations · 29 references

DOIFull text

Open access

Concepts

References

29

A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

Andrew S. Levey, Juan Bosch, Julia B. Lewis et al. · Annals of Internal Medicine · 1999 · 15.1K citations

, , +17

KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease

Paul E. Stevens, Sofia B. Ahmed, Juan Jesús Carrero et al. · Kidney International · 2024 · 7.4K citations · Full text

, , +17

Once-Weekly Semaglutide in Adults with Overweight or Obesity

John Wilding, Rachel L. Batterham, Salvatore Calanna et al. · New England Journal of Medicine · 2021 · 4.5K citations · Full text

, , +11

Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021

Kanyin Liane Ong, Lauryn K Stafford, Susan A. McLaughlin et al. · The Lancet · 2023 · 4.2K citations · Full text

, , +16

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

A. Michael Lincoff, Kirstine Brown‐Frandsen, Helen M. Colhoun et al. · New England Journal of Medicine · 2023 · 2.6K citations · Full text

, , +17